Conditions: Severe Hepatic Impairment Healthy
Keywords: Severe Hepatic Impairment Healthy
Allocation: NON_RANDOMIZED | Intervention model: SEQUENTIAL
Enrollment: 12
Healthy volunteers: yes

Brief summary:
This is an open-label, single-dose study in male and female subjects with severe hepatic impairment and in male and female subjects with normal hepatic function.

Detailed description:

Arms:
arm 1: HP PK MCI-186 arm 2: NHV PK MCI-186

Interventions: intervention 1: MCI-186
Intervention descriptions: intervention 1: 30 mg MCI-186 will be administered intravenously over 60 minutes.

Protocol document:
Prot_000.pdf: 





















































































































































SAP_001.pdf: